Home / Cardiovascular system / Telmisartan and Amlodipine
ATC C09DB04 · Angiotensin II Receptor Blockers (ARBs) and Calcium Channel Blockers
Telmisartan and Amlodipine shortage
As of 2 Nov 2026, Telmisartan and Amlodipine has a reported shortage in 3 of the 15 countries we track (Canada, Czechia, Japan), covering 21 products from 8 companies.
Countries3/15
Products21packs or presentations
Companies84 listed
Short since23 Feb 20224.7 years ago
Earliest return14 Dec 2026company estimate
Main reasonIncreased demand
United StatesNo reported shortageCanada5 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia2 products shortNorwayNo reported shortageSwedenNo reported shortageJapan14 products shortAustraliaNo reported shortage
Timeline
CanadaCzechiaJapan
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Nipro 8086 · Tokyo, Sawai 4887 · Tokyo, Daiichi Sankyo 4568 · Tokyo, Towa (Pensa) 4553 · Tokyo
Compared with similar medicines
ATC group C09DB · Angiotensin II Receptor Blockers (ARBs) and Calcium Channel BlockersAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | AA-TELMISARTAN-AMLODIPINE (100BTL) | AA PHARMA INC | 23 Feb 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | AA-TELMISARTAN-AMLODIPINE (100BTL) | AA PHARMA INC | 6 Apr 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TWYNSTA (4x7) | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 15 Oct 2026 | 4 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TWYNSTA (4x7) | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 29 Oct 2026 | 1 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TWYNSTA (4x7) anticipated | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 27 Nov 2026 | 14 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CZ | TEZEFORT 80MG/5MG 80MG/5MG TBL NOB 90 anticipated | Zentiva, k.s., Praha | 9 Nov 2026 | 18 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | TEZEFORT 80MG/5MG 80MG/5MG TBL NOB 28 anticipated | Zentiva, k.s., Praha | 13 Nov 2026 | 18 Dec 2026 | Manufacturing problem Výrobní důvody |
| JP | テラムロ配合錠AP「EE」 limited | ニプロファーマ | 14 May 2025 | not given | Increased demand |
| JP | テラムロ配合錠BP「EE」 limited | ニプロファーマ | 14 May 2025 | not given | Increased demand |
| JP | テラムロ配合錠AP「サワイ」 limited | 沢井製薬 | 15 May 2025 | not given | Increased demand |
| JP | テラムロ配合錠BP「サワイ」 limited | 沢井製薬 | 15 May 2025 | not given | Increased demand |
| JP | テラムロ配合錠AP「NIG」 limited | 日医工岐阜工場 | 16 May 2025 | not given | Increased demand |
| JP | テラムロ配合錠BP「NIG」 limited | 日医工岐阜工場 | 16 May 2025 | not given | Increased demand |
| JP | ミカムロ配合錠AP limited | 日本ベーリンガーインゲルハイム | 30 May 2025 | not given | Increased demand |
| JP | ミカムロ配合錠BP limited | 日本ベーリンガーインゲルハイム | 30 May 2025 | not given | Increased demand |
| JP | テラムロ配合錠AP「DSEP」 limited | 第一三共エスファ | 27 Oct 2025 | not given | Increased demand |
| JP | テラムロ配合錠BP「DSEP」 limited | 第一三共エスファ | 27 Oct 2025 | not given | Increased demand |
| JP | テラムロ配合錠AP「ニプロ」 | ニプロ | 5 Nov 2025 | not given | Other |
| JP | テラムロ配合錠BP「ニプロ」 | ニプロ | 5 Nov 2025 | not given | Other |
| JP | テラムロ配合錠AP「トーワ」 limited | 東和薬品 | 30 Oct 2026 | not given | Manufacturing problem |
| JP | テラムロ配合錠BP「トーワ」 limited | 東和薬品 | 30 Oct 2026 | not given | Manufacturing problem |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.